skip to main content
Close Icon

This website uses cookies. By continuing to use this site, you agree to our use of cookies. To find out more visit our Cookie Policy page.

Global Search Configuration

Comprehensive pharma consulting

Pharma intelligence consulting

Need outside expertise? Lack available staff? Want an objective perspective? Pharma Consulting works with you to produce actionable, flexible solutions tailored to your needs. Our services help you discover new business opportunities, reduce risks, and make better, faster decisions.

 

How we help

You’ll benefit from:

• Customized approach - solutions to fit your situation
• Joint problem/opportunity definition
• Proprietary data and complementary market research
• 500+ industry experts
• Collaborative problem solving
• Fact-based decisions and actionable recommendations
• Ownership of final decisions and action plans

 

How it works

We specialize in pharma portfolio management, commercial optimization, and research and development strategy – whatever your business needs, we have competent experts to partner with you.

  • Receive customized research and analysis that transforms information into actionable development plans. We cover: Clinical trials
  • Drugs
  • Sites
  • Likelihood of approval
  • Probability of technical success
  • Loss of exclusivity
  • Lifecycle management
  • Pipeline and net present value
  • Revenue forecasts
  • Market access factors
  • Partnership and licensing opportunities and more

 

Get recommendations on capturing the full commercial potential of a product, portfolio or market opportunity, and understand the value and associated risk/return for your drug development portfolio. 

What's included

Best in class datasets

Best-in-class datasets

Authoritative data from our market-leading intelligence sources  

 

consultancies pharma intelligence

Leading industry experts

Expertise drawn from a team of over 100 seasoned, industry specialists 

Robust solutions

Robust, actionable solutions

Insight & value to help you make confident strategic decisions

Global market experience

Global market experience

Support for big pharma, mid-tier, biotech, generics, & medical device companies

 

Our Solutions

We deliver clear information, analysis, and recommendations to support your commercialization and portfolio strategies.
We help you understand the expected value and associated risks across your drug development portfolio.

We provide customized research and analysis that transforms information on clinical trials, drugs and sites into actionable intelligence for your organization.

Citeline Analytics provides customized research and analysis that transforms information on pharmaceutical clinical trials, drugs and sites into actionable intelligence for your organization.

 

View more
View Less

Case studies

  • Pharma Consulting

    Commercial optimization

    By Pharma Intelligence 13 Sep 2017

    The Issue Our client asked us to help support their CNS product portfolio strategy by helping to understand the clinical and commercial potential of the schizophrenia market

  • Pharma Consulting

    Competitive landscape assessment and monitoring

    11 Sep 2017

    The Issue: A global pharmaceutical company needed to assess the current and future competitive landscape of an early-stage analog drug to determine the possibilities of market entry and the viability of possible differentiation strategies to compete in the market. 

  • Pharma Consulting

    Benchmarking Loss of Exclusivity (LOE) and Price Evolution

    11 Sep 2017

    The Issue: Our client wished to understand the potential impact of the competitor’s drug going generic on their brand and whether there would be any spill-over effects.

  • Pharma Consulting

    Qualitative market research with payers in the EU and Japan

    By Pharma Intelligence 01 Jan 2016

    The Issue: The client was looking to develop a deeper understanding of the payer landscape in Europe and Japan as part of an overall market opportunity assessment

  • Pharma Consulting

    Probability of Technical Success

    By Pharma Intelligence 01 Jan 2016

    Issue A large biotech needed the correct analogs for follow-on biologics PTS in Oncology and Respiratory programs across a range of segments to assess the risk of their portfolio  

Meet the team

Management

Susan Danheiser

Management, Director - Pharma Consulting

Boston

Susan Danheiser

Susan specializes in

  • Deals & Financing
  • Commercial Strategy

+21 year(s) experience

Management

Timothy Pang

Management, Director- Pharma consulting
Timothy Pang

Timothy specializes in

  • Deals & Financing
  • Commercial Strategy

+21 year(s) experience

Management

Ellen Moore

Management, Director - Pharma Consulting

New York

Ellen Moore

Ellen specializes in

  • Deals & Financing
  • Commercial Strategy

+16 year(s) experience

Next steps

For a personal discussion, please email us your inquiry, so we can provide you the best possible customer service:  

pharma@informa.com

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: